Urologic Oncology: Seminars and Original Investigations
Volume 29, Issue 6 , Pages 614-623 , November 2011

Reliability of the 34βE12, keratin 5/6, p63, bcl-2, and AMACR in the diagnosis of prostate carcinoma

  • Cetin Boran, M.D.

      Affiliations

    • Department of Pathology, Abant Izzet Baysal University, Medical Faculty, Bolu, Turkey
    • Corresponding Author InformationCorresponding author. Tel.: +90-374-253-46-56; fax: +90-374-253-45-59
  • ,
  • Engin Kandirali, M.D.

      Affiliations

    • Department of Urology, Abant Izzet Baysal University, Medical Faculty, Bolu, Turkey
  • ,
  • Fahri Yilmaz, M.D.

      Affiliations

    • Department of Pathology, Abant Izzet Baysal University, Medical Faculty, Bolu, Turkey
  • ,
  • Erdinc Serin, M.D.

      Affiliations

    • Department of Biochemistry, Abant Izzet Baysal University, Medical Faculty, Bolu, Turkey
  • ,
  • Mesut Akyol, M.Sc.

      Affiliations

    • Department of Biostatistics, Gulhane Military Medical Academy, Ankara, Turkey

Received 19 June 2009 ,Revised 19 November 2009 ,Accepted 20 November 2009.

References 

  1. Iczkowski KA, Chen HM, Yang XJ, et al. Prostate cancer diagnosed after initial biopsy with atypical small acinar proliferation suspicious for malignancy is similar to cancer found on initial biopsy. Urology. 2002;60:851–854
  2. Molinié V, Hervé JM, Lugagne PM, et al. Diagnostic utility of a p63/α-methyl coenzyme A racemase (p504s) cocktail in ambiguous lesions of the prostate upon needle biopsy. BJU Int. 2006;97:1109–1115
  3. Shah RB, Zhou M, LeBlanc M, et al. Comparison of the basal cell-specific markers, 34βE12, and p63, in the diagnosis of prostate cancer. Am J Surg Pathol. 2002;26:1161–1168
  4. Yan-Gao M, Zhao C, Chen X. A subset of prostate basal cells lacks the expression of corresponding phenotypic markers. Pathol Res Pract. 2006;202:651–662
  5. Martens MB, Keller JH. Routine immunohistochemical staining for high-molecular weight cytokeratin 34-β and α-methylacyl CoA racemase (P504S) in postirradiation prostate biopsies. Mod Pathol. 2006;19:287–290
  6. Srigley JR. Benign mimickers of prostatic adenocarcinoma. Mod Pathol. 2004;17:328–348
  7. Evans AJ. α-Methylacyl CoA racemase (P504S): Overview and potential uses in diagnostic pathology as applied to prostate needle biopsies. Am J Clin Pathol. 2003;56:892–897
  8. Varma M, Linden MD, Amin MB. Effect of formalin fixation and epitope retrieval techniques on antibody 34βE12 immunostaining of prostatic tissues. Mod Pathol. 1999;12:472–478
  9. Epstein JI. Diagnosis and reporting of limited adenocarcinoma of the prostate on needle biopsy. Mod Pathol. 2004;17:307–315
  10. Humphrey PA. Diagnosis of adenocarcinoma in prostate needle biopsy tissue. J Clin Pathol. 2007;60:35–42
  11. Abrahams NA, Ormsby AH, Brainard J. Validation of cytokeratin 5/6 as an effective substitute for keratin 903 in the differentiation of benign from malignant glands in prostate needle biopsies. Histopathology. 2002;41:35–41
  12. Diaz JI, Pow-Sang JM, Mora LB, et al. Cytometric analysis of Fas and Bcl-2 expression in normal prostatic epithelium and prostate cancer. Urol Oncol. 2000;5:149–154
  13. Zhou M, Aydin H, Kanane H, et al. How often does α-methylacyl-CoA-racemase contribute to resolving an atypical diagnosis on prostate needle biopsy beyond that provided by basal cell markers?. Am J Surg Pathol. 2004;28:239–243
  14. Dawson B, Trap RG. Basic and clinical biostatistics. New York: Lange Medical Books/McGraw Hill; 2004;
  15. Agresti A. Categorical data analysis. New Jersey: John Wiley and Sons, Inc.; 2002;
  16. Molinié V, Fromont G, Sibony M, et al. Diagnostic utility of a p63/α-methyl-CoA-racemase (p504s) cocktail in atypical foci in the prostate. Mod Pathol. 2004;17:1180–1190
  17. Gown AM, Vogel AM. Monoclonal antibodies to human intermediate filament proteins (II. Distribution of filament proteins in normal human tissues). Am J Pathol. 1984;114:309–321
  18. Jiang Z, Wu CL, Woda BA, et al. P504S/α-methylacyl-CoA racemase: A useful marker for diagnosis of small foci of prostatic carcinoma on needle biopsy. Am J Surg Pathol. 2002;26:1169–1174
  19. Paner GP, Luthringer DJ, Amin MB. Best practice in diagnostic immunohistochemistry: Prostate carcinoma and its mimics in needle core biopsies. Arch Pathol Lab Med. 2008;132:1388–1396
  20. Reis-Filho JS, Simpson PT, Martins A, et al. Distribution of p63, cytokeratins 5/6 and cytokeratin 14 in 51 normal and 400 neoplastic human tissue samples using TARP-4 multi-tumor tissue microarray. Virchows Arch. 2003;443:122–132
  21. Carella R, Deleonardi G, D'Errico A, et al. Immunohistochemical panels for differentiating epithelial malignant mesothelioma from lung adenocarcinoma: A study with logistic regression analysis. Am J Surg Pathol. 2001;25:43–50
  22. Chu PG, Weiss LM. Keratin expression in human tissues and neoplasms. Histopathology. 2002;40:403–439
  23. Abrahams NA, Bostwick DG, Ormsby AH, et al. Distinguishing atrophy and high-grade prostatic intraepithelial neoplasia from prostatic adenocarcinoma with and without previous adjuvant hormone therapy with the aid of cytokeratin 5/6. Am J Clin Pathol. 2003;120:368–376
  24. Yang A, McKeon F. P63 and P73: p53 mimics, menaces, and more. Nat Rev Mol Cell Biol. 2000;1:199–207
  25. Weinstein MH, Signoretti S, Loda M. Diagnostic utility of immunohistochemical staining for p63, a sensitive marker of prostatic basal cells. Mod Pathol. 2002;15:1302–1308
  26. Davis LD, Zhang W, Merseburger A, et al. p63 Expression profile in normal and malignant prostate epithelial cells. Anticancer Res. 2002;22:3819–3825
  27. Parsons JK, Gage WR, Nelson WG, et al. p63 Protein expression is rare in prostate adenocarcinoma: Implications for cancer diagnosis and carcinogenesis. Urology. 2001;58:619–624
  28. Signoretti S, Waltregny D, Dilks J, et al. p63 is a prostate basal cell marker and is required for prostate development. Am J Pathol. 2000;157:1769–1775
  29. Shah RB, Kunju LP, Shen R, et al. Usefulness of basal cell cocktail (34βE12 + p63) in the diagnosis of atypical prostate glandular proliferations. Am J Clin Pathol. 2004;122:517–523
  30. Takechi M, Tanaka K, Hashimoto T, et al. Cytogenetic, molecular, biological, and clinical study of B-cell lymphomas with 14;18 translocation in Japanese patients. Leukemia. 1991;5:1069–1075
  31. Maffini MV, Ortega HH, Stoker C, et al. Bcl-2 correlates with tumor ploidy and nuclear morphology in early stage prostate carcinoma (A fine needle aspiration biopsy study). Pathol Res Pract. 2001;197:487–492
  32. Ramos Soler D, Mayordomo Aranda E, Calatayud Blas A, et al. Usefulness of bcl-2 expression as a new basal cell marker in prostatic pathology [Abstract]. Acta Urol Esp. 2006;30:345–352
  33. Sung MT, Jiang Z, Montironi R, et al. α-Methylacyl-CoA racemase (P504S)/34βE12/p63 triple cocktail stain in prostatic adenocarcinoma after hormonal therapy. Hum Pathol. 2007;38:332–341
  34. Yang XJ, Wu CL, Woda BA, et al. Expression of α-methylacyl-CoA racemase (P504S) in atypical adenomatous hyperplasia of the prostate. Am J Surg Pathol. 2002;26:921–925
  35. Beach R, Gown AM, De Peralta-Venturina MN, et al. P504S immunohistochemical detection in 405 prostatic specimens including 376 18-gauge needle biopsies. Am J Surg Pathol. 2002;26:1588–1596
  36. Hameed O, Sublett J, Humphrey PA. Immunohistochemical stains for p63 and α-methylacyl-CoA racemase, vs. a cocktail comprising both, in the diagnosis of prostatic carcinoma: A comparison of the immunohistochemical staining of 430 foci in radical prostatectomy and needle biopsy tissue. Am J Surg Pathol. 2005;29:874–880
  37. Hameed O, Humphrey PA. Immunohistochemistry in diagnostic surgical pathology of the prostate. Semin Diagn Pathol. 2005;22:88–104
  38. Herawi M, Parwani AV, Irie J, et al. Small glandular proliferations on needle biopsies: Most common benign mimickers of prostatic adenocarcinoma sent in for expert second opinion. Am J Surg Pathol. 2005;29:874–880

 This study was supported by grant 2008.08.02.275 from Abant Izzet Baysal University.

PII: S1078-1439(09)00366-4

doi: 10.1016/j.urolonc.2009.11.013

Urologic Oncology: Seminars and Original Investigations
Volume 29, Issue 6 , Pages 614-623 , November 2011